Point of Care Devices Market Report 2025

The point of care devices market size has grown strongly in recent years. It will grow from $28.7 billion in 2024 to $31.46 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth during the historic period can be attributed to increasing awareness of early disease detection, rising adoption of portable healthcare devices, growing demand for decentralized testing, expanding government initiatives to improve healthcare accessibility, and rising global healthcare expenditure.

The point of care devices market size is expected to see strong growth in the next few years. It will grow to $44.84 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth during the forecast period can be attributed to the increasing adoption of wireless and connected devices, growing focus on point-of-care testing in remote areas, rising emphasis on cost-effective diagnostics, higher investments in healthcare infrastructure, increasing prevalence of infectious diseases, and growing demand for multi-parameter testing devices. Key trends expected during the forecast period include advancements in lab-on-a-chip technology, development of AI-powered diagnostic platforms, innovations in smartphone-integrated testing devices, enhancements in multiplex testing capabilities, and the emergence of cloud-connected point-of-care systems.

The growing demand for diagnostic imaging is expected to drive the expansion of the point-of-care devices market in the coming years. Diagnostic imaging involves techniques and processes used to generate visual representations of the interior of the body for clinical evaluation and medical intervention. This demand is rising due to the increasing prevalence of chronic diseases that require early and accurate diagnosis. Point-of-care devices support diagnostic imaging by providing compact, portable solutions suitable for clinics, bedside, and remote healthcare settings. They reduce turnaround time by delivering rapid and precise imaging results, enhancing clinical decision-making and overall patient care efficiency. For example, in February 2025, a survey study conducted by the National Library of Medicine among 348,214,053 insured individuals including those with Medicare fee-for-service, Medicare Advantage, Medicaid, and commercial insurance from 2018 to 2022 projected imaging utilization to be 16.9% to 26.9% higher in 2055 compared with 2023. Therefore, the increasing demand for diagnostic imaging is fueling the growth of the point-of-care devices market.

Key players in the point-of-care devices market are developing advanced solutions such as AI-powered handheld ultrasound systems to enhance diagnostic accuracy and portability. These systems are portable imaging devices that leverage artificial intelligence algorithms to assist in capturing and interpreting ultrasound images, enabling faster and more accurate diagnoses. For instance, in October 2023, Koninklijke Philips N.V., a Netherlands-based healthcare technology company, launched the Compact 5000 Series, an AI-enhanced point-of-care ultrasound system. This portable device delivers high-quality imaging combined with AI-driven automation for measurements and streamlined workflows, enabling rapid and precise diagnostics across diverse healthcare settings. It features intuitive controls, supports multiple transducers, and integrates seamlessly with telemedicine platforms to facilitate collaborative remote patient care.

In July 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, acquired the point-of-care technology platform from LumiraDx Limited for an undisclosed amount. This acquisition aims to strengthen Roche’s presence in decentralized diagnostics by integrating a user-friendly, portable platform capable of performing immunochemistry and clinical chemistry tests, with potential for future molecular diagnostics. LumiraDx Limited is a UK-based diagnostics company specializing in point-of-care devices.

Major players in the point of care devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Hologic Inc., BioMérieux SA, Quidel Corporation, OraSure Technologies Inc., Nova Biomedical Corporation, Sekisui Diagnostics LLC, Abaxis Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Chembio Diagnostics Inc., PTS Diagnostics LLC, MeMed, Alere Inc., Diagnostics For All Inc.

North America was the largest region in the point of care devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point of care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the point of care devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Point-of-care devices are medical diagnostic tools designed for use at or near the site of patient care, including clinics, hospitals, or even home settings. Their primary purpose is to provide rapid, on-the-spot test results, enabling timely clinical decisions and immediate treatment. These devices simplify complex laboratory tests, making healthcare more efficient and accessible.

The primary types of point-of-care devices include diagnostic devices, therapeutic devices, monitoring devices, treatment devices, and support devices. Diagnostic devices are medical instruments used to detect, measure, and monitor diseases or health conditions by analyzing patient samples or physiological parameters. They employ technologies such as biochemical assays, microfluidics, immunoassays, nucleic acid testing, and wearable technology, and are applied across fields like cardiology, diabetes management, infectious diseases, oncology, and pediatrics. These devices are distributed through channels including direct sales, distributors, online platforms, retail pharmacies, and healthcare institutions, serving end users across these same channels.

The point of care devices are diagnostic devices market research report is one of a series of new reports that provides point of care devices are diagnostic devices market statistics, including point of care devices are diagnostic devices industry global market size, regional shares, competitors with a point of care devices are diagnostic devices market share, detailed point of care devices are diagnostic devices market segments, market trends and opportunities, and any further data you may need to thrive in the point of care devices are diagnostic devices industry. This point of care devices are diagnostic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point of care devices market consists of revenues earned by entities by providing services such as rapid diagnostic testing, decentralized patient monitoring, mobile health diagnostics, chronic disease screening, and real-time clinical decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care devices market also includes sales of portable blood glucose meters, handheld immunoassay analyzers, rapid antigen test kits, mobile hematology analyzers, and compact molecular diagnostic devices. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.